Nasdaq: $30.02 (+4.13) | AIM: £4.27 (+0.57)
News & Presentations
Previous Article   |   Next Article
Oncology / Immunology, RNS Announcements | 20 Aug 2007

Chi-Med Announces Drug Discovery and Development Agreement with Eli Lilly and Company

1 items
a070820